Prognosis is Poorer in Patients with Lung Cancer Who Are HIV-InfectedJohn SchieszerMA
The outlook for patients with lung cancer is poor, so an accurate estimation of prognosis will underpin treatment decisions and allow patients to make personal plans for the future. However, evidence suggests that there is a variation between doctors in their predictions of outcomes and also they ...
is one of the largest and most comprehensive hospitals in Hebei. We collected all the data pertaining to 954 young patients diagnosed with lung cancer at the Fourth Hospital of Hebei Medical University between 1 January 2010 and 31 December 2017. Patients older than 45 years who were diagnosed...
Among 54 mediastinal tumours we examined in the past 20 years, there were 5 cases of primary thymic carcinomas, each with widespread metastases. Histologic... C Hartmann - 《Journal of Cancer Research & Clinical Oncology》 被引量: 89发表: 1990年 Concomitant occurrence of EGFR (epidermal growth...
With the approval of the antiangiogenic antibody bevacizumab in non-small cell lung cancer (NSCLC) and other malignancies, the tumor vasculature has emerged as a worthwhile therapeutic target. Second-line therapies have the potential to improve overall survival and quality of life over best supportive...
data from 5,240 patients diagnosed with lung cancer at the Weihai Municipal Hospital, China. Then, we applied a joint model that combined a BN and a Cox model to predict mortality risk in individual patients with lung cancer. The established prognostic model achieved good predictive performance ...
Conclusion: Despite radical surgery, the relapse-free survival and overall survival in patients with stage Ⅱ and Ⅲa non-small cell lung cancer were disappointment. 展开 关键词: Non-small cell lung cancer Radical surgery Survival Prognostic factor ...
More than 65% of people with stage I lung cancer live for 5 years or more after they're diagnosed. Can stage I lung cancer be removed? Yes, if you are fit enough for surgery, your doctor can remove the part or your lung (or all of your lung) with cancer. ...
An extensive analytical study performed at the Terasaki Institute andpublishedinFrontiers in Immunologyhighlights the crucial role of tissue-resident memory T cells and how they influence the immune environment of patients with non-small cell lung cancer and their overall prognosis. ...
(P<0.003) or squamous cell carcinoma (P=0.023) in the TCGA data set. We validate the survival prediction framework with the TMA cohort (P<0.036 for both tumour types). Our results suggest that automatically derived image features can predict the prognosis of lung cancer patients and thereby ...